Formulation-Level Tolerability of Repeated Drinking-Water Administration of a Commercial Multi-Component Bacteriophage Product in Ross 308 Broiler Chickens: A Pilot 27-Day Dose-Escalation Study
Ádám Kerek, Zsolt Abonyi-Tóth, Péter Ferenc Dobra, Henrik Baranyay, Tamás Maklári, Ákos Jerzsele · 2026
Read Formulation-Level Tolerability of Repeated Drinking-Water Administration of a Commercial Multi-Component Bacteriophage Product in Ross 308 Broiler Chickens: A Pilot 27-Day Dose-Escalation Study by Ádám Kerek, Zsolt Abonyi-Tóth, Péter Ferenc Dobra, Henrik Baranyay, Tamás Maklári, Ákos Jerzsele (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13517655.txt.
Description
Ádám Kerek and five colleagues run a safety-first pilot of a bacteria-killing virus product in broiler chickens in a 2026 study. Bacteriophages, viruses that infect bacteria, promise antibiotic-sparing disease control, yet farm products need tolerance proof before efficacy trials. One hundred twenty Ross 308 birds drank water with Fagovet, a commercial multi-phage mix, for twenty-seven days at the label rate or at threefold and fivefold overdoses, against untreated controls.
Weight gain and feed intake held steady at every dose. No consistent dose-linked pattern of illness, death, or post-mortem damage appeared. The authors are frank about limits: doses were set by product volume, not by counted viruses in the water, and the mix's parts were never separately profiled. They present the results as short-term tolerance of this formulation in unchallenged birds, a green light for stricter studies with measured exposure and real pathogen challenge.
Catalog record
| CREATOR | Ádám Kerek, Zsolt Abonyi-Tóth, Péter Ferenc Dobra, Henrik Baranyay, Tamás Maklári, Ákos Jerzsele |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 35 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |